CRVS - Corvus Pharmaceuticals, Inc.

NasdaqGM - NasdaqGM Real Time Price. Currency in USD
Currency in USD
Earnings EstimateCurrent Qtr. (Jun 2019)Next Qtr. (Sep 2019)Current Year (2019)Next Year (2020)
No. of Analysts2223
Avg. Estimate-0.42-0.41-1.67-1.96
Low Estimate-0.42-0.45-1.76-2.07
High Estimate-0.42-0.37-1.58-1.8
Year Ago EPS-0.4-0.36-1.71-1.67
Revenue EstimateCurrent Qtr. (Jun 2019)Next Qtr. (Sep 2019)Current Year (2019)Next Year (2020)
No. of Analysts1122
Avg. EstimateN/AN/AN/AN/A
Low EstimateN/AN/AN/AN/A
High EstimateN/AN/AN/AN/A
Year Ago SalesN/AN/AN/AN/A
Sales Growth (year/est)N/AN/AN/AN/A
Earnings History6/29/20189/29/201812/30/20183/30/2019
EPS Est.-0.59-0.48-0.46-0.4
EPS Actual-0.4-0.36-0.36-0.4
Difference0.190.120.10
Surprise %32.20%25.00%21.70%0.00%
EPS TrendCurrent Qtr. (Jun 2019)Next Qtr. (Sep 2019)Current Year (2019)Next Year (2020)
Current Estimate-0.42-0.41-1.67-1.96
7 Days Ago-0.41-0.4-1.66-1.89
30 Days Ago-0.41-0.4-1.66-1.89
60 Days Ago-0.42-0.41-1.66-1.9
90 Days Ago-0.53-0.52-1.81-1.83
EPS RevisionsCurrent Qtr. (Jun 2019)Next Qtr. (Sep 2019)Current Year (2019)Next Year (2020)
Up Last 7 DaysN/AN/AN/AN/A
Up Last 30 DaysN/AN/A11
Down Last 7 DaysN/AN/AN/AN/A
Down Last 30 Days1111
Growth EstimatesCRVSIndustrySectorS&P 500
Current Qtr.-5.00%N/AN/A0.02
Next Qtr.-13.90%N/AN/A0.04
Current Year2.30%N/AN/A0.05
Next Year-17.40%N/AN/A0.11
Next 5 Years (per annum)N/AN/AN/A0.10
Past 5 Years (per annum)N/AN/AN/AN/A